All Regulation articles – Page 30
-
Business
US focuses pharma supply chain scrutiny
Import pre-authorisation for trusted firms frees up resources to tackle purity problems
-
Business
UK to fast-track access to critical medicines
Patients could receive medicines before formal approval in exchange for monitoring data
-
BusinessRoche disputes unethical East German trial claims
Internal investigation concludes that 1980s trials were legally run and patients gave proper consent
-
NewsEurope wants to get tough on plastic waste
Parliament sets its sights on lightweight carrier bags and ‘dangerous plastics’
-
Business
US blocks imports from fourth Ranbaxy plant
FDA bans import of active ingredients from factory in Toansa, India
-
Business
Novartis in the spotlight in mis-selling investigations
Crackdown on pharma marketing continues with US and Japanese cases
-
Business
EU chemical agency gives first hazardous substance authorisation
Rolls Royce given first approval to use substance linked to birth defects under controlled conditions
-
Business
Chinese police seize £222m of fake drugs
1300 people are arrested in a nationwide crackdown on counterfeit medicines
-
Opinion
Cut price pills cost more than pennies
We can’t afford to let the demand for cheaper medicines force compromises on quality, says Steven Ford
-
BusinessReach is a big trade barrier, say US manufacturers
Europe says requirements for US companies are the same as for EU competitors
-
Business
Regulator cracks down on 23andMe
Personal genetic profiler ordered to stop selling DNA test kits
-
NewsGlobal treaty on mercury emissions signed
Ratification of the Minamata Convention may still take five years and some green groups are disappointed by its lack of ambition
-
Business
Counterfeit anxiety pills seized in Switzerland
1 million fake tablets were en route from China to Egypt
-
Business
Japan confirms Novartis clinical trial data fabrication
Investigation into blood pressure blockbuster continues
-
BusinessNew respiratory drugs neck and neck
Combination inhalers from GSK and Novartis approved in EU and Japan
-
Business
GSK criticised for trial data secrecy
Italian research institute abandons collaboration over data access
-
Business
UK objects to pesticide ban in gardens
Government disagrees with EU neonicotinoid moratorium, but will implement it
-
Business
First biosimilar antibody drugs approved in Europe
European commission gives final approval to generic infliximab copies
-
Business
Nice rules against Afinitor
Novartis’ drug will not routinely be available on the UK health service